Lymphoepithelioma-like carcinoma of the bladder: a case report - Takeaways - MDSpire

Lymphoepithelioma-like carcinoma of the bladder: a case report

  • By

  • Ying Yu

  • Lei Zhang

  • July 8, 2026

  • 0 min

Share

  • 1

    Lymphoepithelioma-like carcinoma of the bladder (LELCB) is a rare subtype of urothelial carcinoma, comprising less than 1.3% of malignant bladder tumors.

  • 2

    An 86-year-old woman presented with painless gross hematuria and was diagnosed with LELCB after transurethral resection of the bladder tumor.

  • 3

    The patient experienced tumor recurrence 11 months post-surgery despite receiving regular adjuvant chemotherapy with epirubicin hydrochloride.

  • 4

    Postoperative pathology confirmed LELCB after the patient underwent a second transurethral resection due to recurrence.

  • 5

    The patient did not receive further adjuvant therapy due to multiple underlying health conditions and has not undergone follow-up examinations.

Original Source(s)

Lymphoepithelioma-like carcinoma of the bladder: a case report

  • by Ying Yu, Lei Zhang

  • July 8, 2026

Related Content

Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial